Results 21 to 30 of about 11,244 (122)
BIODEGRADAÇÃO DE FÁRMACOS NA ÁGUA POR MICRORGANISMOS BIASSOCIADOS EM FILTROS BIOLÓGICOS DE CARVÃO [PDF]
Revista DAE, 2009 A contaminação por compostos farmacêuticos nos ambientes aquáticos e sua difícil remoção no tratamento convencional de água representam um desafio às companhias de saneamento.
Alessandro Minillo +3 more
doaj +1 more source
European Eating Disorders Review, EarlyView.ABSTRACT Objective To investigate real‐world psychopharmacological prescribing patterns among Italian adolescents with anorexia nervosa (AN) compared with psychiatric controls without eating disorders, and to examine whether AN diagnosis independently predicts medication use after accounting for psychiatric comorbidities.
Marika Orlandi +5 more
wiley +1 more source
Experiencia del Comité de Evaluación de Medicamentos en un Hospital Universitario
Revista del Hospital Italiano de Buenos AiresIntroducción: el exponencial desarrollo de medicamentos innovadores plantea desafíos a los sistemas de salud para garantizar el acceso equitativo a los nuevos tratamientos.
Ana P. Gómez +7 more
doaj +1 more source
Tratamiento farmacológico de la obesidad
Revista Médica Clínica Las Condes, 2012 Para un porcentaje alto de pacientes que no logran controlar su peso solo con modificación de su hábito de alimentación y ejercicio se hace necesario contar con fármacos que apoyen los cambios de estilo de vida.
Álvarez V. Verónica, Dra.
doaj +1 more source
Journal of Applied Toxicology, EarlyView.ABSTRACT The N‐acylhydrazone scaffold is recognized as a privileged structure for the design of bioactive substances with increasing applications in medicinal chemistry research. Ensuring the safety of newly developed molecules is a critical step for both human health and environmental protection. Accordingly, this study aimed to evaluate the cytotoxic
Larissa Ribeiro Canuto Santos +4 more
wiley +1 more source
Ponatinib: A Review of the History of Medicinal Chemistry behind Its Development
PharmaceuticalsThe primary treatment for chronic myeloid leukemia (CML) involves first- and second-generation tyrosine kinase inhibitors (TKIs), such as imatinib, nilotinib, bosutinib, and dasatinib.
Mayara Nascimento +11 more
doaj +1 more source
Symposium 18: Drug therapy available in Argentina
Revista de la Sociedad Argentina de Diabetes, 2022 Understanding the physiology of body weight control, which defends the body against weight loss and drives the recovery of lost weight, has shown great advances in the therapeutic goals of a chronic disease such as obesity.
María Yuma
doaj +1 more source
Nanomaterials' Multigenerational Effects by Single and Joint Exposure in Non‐mammalian Models
Environmental Toxicology, EarlyView.ABSTRACT Nanotoxicology has mainly focused on single‐generation studies, leaving multigenerational toxicity underexplored. Having animal welfare recently gained importance, we aimed to provide the state‐of‐the‐art of knowledge about multigenerational effects in non‐mammalian models in the case of nanomaterials (NM) single and joint exposure to other ...
Andy Joel Taipe Huisa +9 more
wiley +1 more source
Developmental Medicine &Child Neurology, EarlyView.Resumen Objetivo Describir la experiencia de progenitores de niños y adolescentes con síndrome de Dravet en relación con el impacto de las olas de calor o las altas temperaturas ambientales en las crisis epilépticas de sus hijos, así como las estrategias de afrontamiento empleadas.
Angel Aledo‐Serrano +8 more
wiley +1 more source
INFLUÊNCIA DE FÁRMACOS SOBRE A FORMAÇÃO DE ÚLCERAS POR PRESSÃO: REVISÃO INTEGRATIVA
Revista Enfermagem Contemporânea, 2016 Objetivo: objetivou-se caracterizar a produção científica acerca da influência de fármacos sobre a formação de úlceras por pressão (UPP). Método: foi realizada uma revisão integrativa, de abordagem qualitativa, no SciELO, BDENF e LILACS. Utilizando-se os
Ana Fabia Salgado de Almeida +5 more
doaj +1 more source